Health ❯Healthcare ❯Medical Research ❯Clinical Studies

Patient Outcomes

Umbilical-Cord-Derived Cell Therapy Reduces Disease Activity in Children With Rare Skin Disorder

INmuneBio’s commitment to a year of free infusions underpins a 12-month open-label study designed to support regulatory approval

Experts Urge Physicians to Adopt Numeric Risk Strategies to Improve Patient Decision-Making